Metabolomics,Unknown,Transcriptomics,Genomics,Proteomics

Dataset Information

0

Expression Data from Allogeneic Human Mesenchymal Stem Cells and Primary Cultures of Human Alveolar Epithelial Type II Cells


ABSTRACT: Acute lung injury (ALI) or acute respiratory distress syndrome (ARDS) is a severe syndrome affecting more than 200,000 patients annually in the U.S. New studies are needed to understand the biological and clinical mechanisms that impair alveolar epithelial function. Also, innovative therapies are needed for the resolution of pulmonary edema in ARDS. We and other investigators have reported that bone marrow derived mesenchymal stem cells (MSCs) are effective in preclinical models of ALI due to their ability to secrete several paracrine factors that can regulate lung endothelial and epithelial permeability, including growth factors, anti-inflammatory cytokines, and antimicrobial peptides. So in this study we will test the therapeutic value of human MSCs in an in vitro model of acute lung injury induced by pro-inflammatory cytokines. We will identify differentially expressed genes in primary cultures of human alveolar epithelial type II cells and human bone marrow derived mesenchymal stem cells using Affymetrix gene expression arrays. Human mesenchymal stem cells (MSCs) and human alveolar epithelial type II cells were co-cultured in a transwell system. The cells were stimulated with cytomix (a combination of different pro-inflammatory cytokines) under different conditions. Cells were harvested for Affymetrix gene expression arrays. Total 25 samples are analyzed, 3~5 replicates are included.

ORGANISM(S): Homo sapiens

SUBMITTER: Michael Matthay 

PROVIDER: E-GEOD-68610 | biostudies-arrayexpress |

REPOSITORIES: biostudies-arrayexpress

altmetric image

Publications

Human Mesenchymal Stem (Stromal) Cells Promote the Resolution of Acute Lung Injury in Part through Lipoxin A4.

Fang Xiaohui X   Abbott Jason J   Cheng Linda L   Colby Jennifer K JK   Lee Jae Woo JW   Levy Bruce D BD   Matthay Michael A MA  

Journal of immunology (Baltimore, Md. : 1950) 20150626 3


Previous studies demonstrated that bone marrow-derived mesenchymal stem (stromal) cells (MSCs) reduce the severity of acute lung injury in animal models and in an ex vivo perfused human lung model. However, the mechanisms by which MSCs reduce lung injury are not well understood. In the present study, we tested the hypothesis that human MSCs promote the resolution of acute lung injury in part through the effects of a specialized proresolving mediator lipoxin A4 (LXA4). Human alveolar epithelial t  ...[more]

Similar Datasets

2015-07-08 | GSE68610 | GEO
2023-06-15 | E-MTAB-12959 | biostudies-arrayexpress
2015-09-30 | GSE47625 | GEO
2008-02-02 | GSE10361 | GEO
2019-07-11 | PXD014070 | Pride
2023-08-13 | PXD040288 | Pride
2024-03-20 | GSE236215 | GEO
2015-11-10 | E-GEOD-65561 | biostudies-arrayexpress
2010-12-22 | E-GEOD-26272 | biostudies-arrayexpress
2014-11-23 | E-GEOD-46053 | biostudies-arrayexpress